GLENMARK PHARMACEUTICALS (GLENMARK) financials — quarterly results, P&L, cash flow, balance sheet, shareholding
Glenmark Pharmaceuticals Ltd is a global research-led pharmaceutical company with presence across generics, Specialty and OTC business with operations in over 80 countries.[1]
Glenmark Pharmaceuticals
GLENMARK
Market Cap₹61,846Cr.
Current Price₹2,192
High / Low₹2,474/1,793
Stock P/E38.6
Book Value₹856
Dividend Yield0.11%
ROCE6.51%
ROE6.58%
Face Value₹1.00
Glenmark Pharmaceuticals Ltd is a global research-led pharmaceutical company with presence across generics, Specialty and OTC business with operations in over 80 countries.[1]
Quarterly Results
Yearly Results
Shareholding Pattern
Shareholding Trend
Balance Sheet
Cash Flows
Last updated at: 24 July 2026 at 19:56:21